Correlation between Contrast-enhanced Ultrasound and Risk of Tumor Recurrence in Papillary Thyroid Carcinoma.

Author: Wen LI ¹ ; Yan ZHANG ² ; Qing SONG ² ; Yu LAN ² ; Hong-Ying HE ² ; Jun MA ² ; Jia-Hang ZHAO ² ; Yi LI ² ; Yu-Kun LUO ¹
Author Information

1. Department of Ultrasound,Medical School of Chinese PLA,Beijing 100853,China.
2. Department of Ultrasound,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China.
Publication Type:Journal Article
Keywords: contrast-enhanced ultrasound; papillary thyroid carcinoma; risk of tumor recurrence; ultrasonography
MeSH: Humans; Neoplasm Recurrence, Local/diagnostic imaging*; Thyroid Cancer, Papillary/diagnostic imaging*; Thyroid Neoplasms/diagnostic imaging*; Ultrasonography
From: Acta Academiae Medicinae Sinicae 2021;43(3):343-349
CountryChina
Language:Chinese
Abstract: Objective To explore the association between contrast-enhanced ultrasound and risk of tumor recurrence in papillary thyroid carcinoma(PTC). Methods A total of 287 PTCs in 287 patients who underwent surgery,conventional ultrasound,and contrast-enhanced ultrasound(CEUS)were enrolled in this study.According to 2015 American Thyroid Association(ATA)Modified Initial Risk Stratification System,the patients were categorized into three groups:low risk,intermediate risk,and high risk.The CEUS patterns of PTCs were compared between different risk stratifications. Results Hypo-enhancement was presented in 57.6% of ATA low-risk PTCs,iso-enhancement in 62.3% of ATA intermediate-risk PTCs,and hyper-enhancement in 48.2% of ATA high-risk PTCs(